Tech Company Financing Transactions
ChemoCentryx Funding Round
On 8/24/2006, ChemoCentryx raised $17.7 million in Series C funding from Alta Partners, HBM Healthcare Investments and OrbiMed.
Transaction Overview
Company Name
Announced On
8/24/2006
Transaction Type
Venture Equity
Amount
$17,700,000
Round
Series C
Proceeds Purpose
The funds will be used to continue to build value in ChemoCentryx and their pipeline of chemokine-based medicines.
Company Information
Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
850 Maude Ave.
Mountain View, CA 94043
USA
Mountain View, CA 94043
USA
Phone
Website
Email Address
Overview
ChemoCentryx develops orally-administered small molecule therapeutics that target chemokine receptors and related chemo-attractants.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Thomas Schall
Chief Financial Officer
Susan Kanaya
VP - Bus. Development
Markus Cappel
VP - Bus. Development
Dalia Rayes
VP - R & D
Rajinder Singh
Browse more venture capital transactions:
Prev: 8/23/2006: Ablynx venture capital transaction
Next: 8/24/2006: iVivity venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We do our best to report on every notable VC transaction. VC investment data records on this site are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs